ADL- Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)

This study has been completed.
Sponsor:
Information provided by:
LHL Helse
ClinicalTrials.gov Identifier:
NCT00887705
First received: April 14, 2009
Last updated: June 22, 2010
Last verified: June 2010
  Purpose

ADL training of copd patients results in better execution of activities of daily living.


Condition Intervention
Chronic Obstructive Pulmonary Disease
Behavioral: ADL training

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Activities of Daily Living (ADL)-Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)

Resource links provided by NLM:


Further study details as provided by LHL Helse:

Primary Outcome Measures:
  • Canadian Occupational Performance Measure(COPM) - Self-perception of occupational performance and satisfaction. [ Time Frame: Baseline, 4 weeks; 3 months ] [ Designated as safety issue: No ]

Enrollment: 24
Study Start Date: May 2009
Study Completion Date: June 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1: Standard rehabilitation programme
Experimental: 2. Additional ADL training Behavioral: ADL training
The control group gets the standard rehabilitation programme which includes one hour ADL- training. The experimental group also gets the standard rehabilitation program, but instead of one hour they get an additional five hours ADL- training.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD
  • Referred for rehabilitation
  • Age > 18 years
  • Symptoms affecting ADL function
  • 6 minute walk distance (6MWD) < 400 meters

Exclusion Criteria:

  • Patients who smokes or has smoked during the last three months.
  • LTOT
  • Patients who has another disability
  • Patients who can`t read or speak Norwegian
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00887705

Locations
Norway
Glittreklinikken
Hakadal, Akershus, Norway, 1485
Glittreklinikken
Hakadal, Norway, 1485
Sponsors and Collaborators
LHL Helse
Investigators
Study Director: Morten S Ryg, Dr philos LHL Helse
  More Information

Additional Information:
No publications provided

Responsible Party: Morten Ryg, Glittreklinikken
ClinicalTrials.gov Identifier: NCT00887705     History of Changes
Other Study ID Numbers: GK-63
Study First Received: April 14, 2009
Last Updated: June 22, 2010
Health Authority: Norway:National Committee for Medical and Health Research Ethics
Norway: Norwegian Institute of Public Health

Keywords provided by LHL Helse:
COPD
Pulmonary Rehabilitation
ADL-Training
COPD Rehabilitation

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on October 30, 2014